These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 34311633)
1. Natural multi-target modulators of pathological pathways in Alzheimer's disease isolated from the Spinelli R; Rietmann Á; Sanchis I; Siano ÁS Nat Prod Res; 2022 Jun; 36(12):3193-3197. PubMed ID: 34311633 [TBL] [Abstract][Full Text] [Related]
2. Amphibian skin extracts as source of bioactive multi-target agents against different pathways of Alzheimer's disease. Spinelli R; Aimaretti FM; López JA; Siano AS Nat Prod Res; 2021 Feb; 35(4):686-689. PubMed ID: 30931620 [TBL] [Abstract][Full Text] [Related]
3. Natural Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidase Enzymes with Antioxidant Potential from Skin Extracts of Hypsiboas cordobae and Pseudis minuta (Anura: Hylidae). Spinelli R; Sanchis I; Aimaretti FM; Attademo AM; Portela M; Humpola MV; Tonarelli GG; Siano AS Chem Biodivers; 2019 Jan; 16(1):e1800472. PubMed ID: 30412651 [TBL] [Abstract][Full Text] [Related]
4. Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors. Reis J; Cagide F; Valencia ME; Teixeira J; Bagetta D; Pérez C; Uriarte E; Oliveira PJ; Ortuso F; Alcaro S; Rodríguez-Franco MI; Borges F Eur J Med Chem; 2018 Oct; 158():781-800. PubMed ID: 30245401 [TBL] [Abstract][Full Text] [Related]
5. Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease. Knez D; Sova M; Košak U; Gobec S Future Med Chem; 2017 May; 9(8):811-832. PubMed ID: 28504893 [TBL] [Abstract][Full Text] [Related]
6. N-alkylpiperidine carbamates as potential anti-Alzheimer's agents. Košak U; Strašek N; Knez D; Jukič M; Žakelj S; Zahirović A; Pišlar A; Brazzolotto X; Nachon F; Kos J; Gobec S Eur J Med Chem; 2020 Jul; 197():112282. PubMed ID: 32380361 [TBL] [Abstract][Full Text] [Related]
7. Cyanobiphenyls: Novel H Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977 [TBL] [Abstract][Full Text] [Related]
8. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease. Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984 [TBL] [Abstract][Full Text] [Related]
9. Dual functional cholinesterase and MAO inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of homoisoflavonoid derivatives. Wang Y; Sun Y; Guo Y; Wang Z; Huang L; Li X J Enzyme Inhib Med Chem; 2016; 31(3):389-97. PubMed ID: 25798687 [TBL] [Abstract][Full Text] [Related]
10. First Synthesis of Racemic Guieu B; Lecoutey C; Legay R; Davis A; Sopkova de Oliveira Santos J; Altomare CD; Catto M; Rochais C; Dallemagne P Molecules; 2020 Dec; 26(1):. PubMed ID: 33375412 [TBL] [Abstract][Full Text] [Related]
11. A review on flavonoid-based scaffolds as multi-target-directed ligands (MTDLs) for Alzheimer's disease. Jalili-Baleh L; Babaei E; Abdpour S; Nasir Abbas Bukhari S; Foroumadi A; Ramazani A; Sharifzadeh M; Abdollahi M; Khoobi M Eur J Med Chem; 2018 May; 152():570-589. PubMed ID: 29763806 [TBL] [Abstract][Full Text] [Related]
12. Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ Plazas E; Hagenow S; Avila Murillo M; Stark H; Cuca LE Bioorg Chem; 2020 May; 98():103722. PubMed ID: 32155491 [TBL] [Abstract][Full Text] [Related]
13. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease. Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Tan Z Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents. Yang J; Zhang P; Hu Y; Liu T; Sun J; Wang X J Enzyme Inhib Med Chem; 2019 Dec; 34(1):651-656. PubMed ID: 30746966 [TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases. Mathew B; Parambi DGT; Mathew GE; Uddin MS; Inasu ST; Kim H; Marathakam A; Unnikrishnan MK; Carradori S Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900177. PubMed ID: 31478569 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids. Sun Y; Chen J; Chen X; Huang L; Li X Bioorg Med Chem; 2013 Dec; 21(23):7406-17. PubMed ID: 24128814 [TBL] [Abstract][Full Text] [Related]
18. Sarsasapogenin: A steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer's disease. Kashyap P; Muthusamy K; Niranjan M; Trikha S; Kumar S Steroids; 2020 Jan; 153():108529. PubMed ID: 31672628 [TBL] [Abstract][Full Text] [Related]
19. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties. Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535 [TBL] [Abstract][Full Text] [Related]
20. Rational Design of Novel Selective Dual-Target Inhibitors of Acetylcholinesterase and Monoamine Oxidase B as Potential Anti-Alzheimer's Disease Agents. Xu Y; Zhang J; Wang H; Mao F; Bao K; Liu W; Zhu J; Li X; Zhang H; Li J ACS Chem Neurosci; 2019 Jan; 10(1):482-496. PubMed ID: 30110536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]